בטאהיסטין טבע  16 מג ישראל - עברית - Ministry of Health

בטאהיסטין טבע 16 מג

abic marketing ltd, israel - betahistine dihydrochloride - טבליה - betahistine dihydrochloride 16 mg - betahistine - betahistine - meniere's syndrom. symptomatic treatment of peripheral vertigo.

אגיסרק 16 ישראל - עברית - Ministry of Health

אגיסרק 16

padagis israel pharmaceuticals ltd, israel - betahistine dihydrochloride - טבליה - betahistine dihydrochloride 16 mg - betahistine - betahistine - meniere's syndrom. symptomatic treatment of peripheral vertigo.

בטיסטין 16 מג ישראל - עברית - Ministry of Health

בטיסטין 16 מג

rafa laboratories ltd - betahistine hydrochloride - טבליה - betahistine hydrochloride 16 mg - betahistine - betahistine - meniere`s syndrome. symptomatic treatment of peripheral vertigo.

בטיסטין 16 מ"ג ישראל - עברית - Ministry of Health

בטיסטין 16 מ"ג

rafa laboratories ltd - betahistine hydrochloride 16 mg - tablets - betahistine - meniere`s syndrome. symptomatic treatment of peripheral vertigo.

קסנזין 25 מ"ג ישראל - עברית - Ministry of Health

קסנזין 25 מ"ג

megapharm ltd - tetrabenazine 25 mg - tablets - tetrabenazine - movement disorders, associated with organic central nervous system conditions, e.g. huntington's chorea, hemiballismus and senile chorea.moderate to severe tardive dyskinesia, which is disabling and/or socially embanassing. the condition should be persistent despite a switch to atypical antipsychotic medication and/or reduction in dosage of antipsychotic medication, when withdrawal of antipsychotic medication is not a realistic option.

קסנזין 25 מג ישראל - עברית - Ministry of Health

קסנזין 25 מג

neopharm ltd, israel - tetrabenazine - טבליה - tetrabenazine 25 mg - tetrabenazine - tetrabenazine - movement disorders, associated with organic central nervous system conditions, e.g. huntington's chorea, hemiballismus and senile chorea.moderate to severe tardive dyskinesia, which is disabling and/or socially embanassing. the condition should be persistent despite a switch to atypical antipsychotic medication and/or reduction in dosage of antipsychotic medication, when withdrawal of antipsychotic medication is not a realistic option.